nicotinuric acid has been researched along with Kidney Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bode-Böger, SM; Luley, C; Martens-Lobenhoffer, J; Reiche, I; Tröger, U; Westphal, S | 1 |
1 other study(ies) available for nicotinuric acid and Kidney Diseases
Article | Year |
---|---|
Pharmacokinetics and dose recommendations of Niaspan® in chronic kidney disease and dialysis patients.
Topics: Aged; Chronic Disease; Cohort Studies; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hypolipidemic Agents; Kidney Diseases; Male; Middle Aged; Niacin; Niacinamide; Nicotinic Acids; Prospective Studies; Renal Dialysis; Survival Rate; Tissue Distribution; Treatment Outcome | 2011 |